Opendata, web and dolomites


Revealing the ubiquitin and ubiquitin-like modification landscape in health and disease

Total Cost €


EC-Contrib. €






 Ubl-Code project word cloud

Explore the words cloud of the Ubl-Code project. It provides you a very rough idea of what is the project "Ubl-Code" about.

operate    decipher    code    therapeutics    shown    enzymes    tool    downstream    broadened    genomic    imaging    translational    form    remained    protein    determined    enzymatic    ptm    ubl    throughput    pathogenesis    signalling    proteomic    stability    vivo    ample    broadly    function    cancer    mechanisms    proteins    events    specify    elucidate    cell    conjugation    ptms    deciphering    regulation    analyze    network    profoundly    profiling    edge    unexplored    opportunity    paradigm    variety    substrates    regulate    acid    molecular    substrate    dynamic    principles    progression    monitor    dynamics    initiate    specificity    relatively    aberrations    post    cutting    vitro    differentiation    modifying    decade    rely    uses    understand    modified    characterization    ubiquitin    diseases    modifications    ms    regulatory    appropriate    technologies    localization    cellular    fundamental    implicated    landscape    reveal    backbone    machinery    biological    subsequent    amino    underlying    questions    division    basis    sequence    utilize    revealing    transcriptional    recognition   

Project "Ubl-Code" data sheet

The following table provides information about the project.


Organization address
address: HERZL STREET 234
postcode: 7610001

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 1˙500˙000 €
 EC max contribution 1˙500˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2015-STG
 Funding Scheme ERC-STG
 Starting year 2016
 Duration (year-month-day) from 2016-05-01   to  2021-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    WEIZMANN INSTITUTE OF SCIENCE IL (REHOVOT) coordinator 1˙500˙000.00


 Project objective

Post-translational modifications (PTMs) of proteins are a major tool that the cell uses to monitor events and initiate appropriate responses. While a protein is defined by its backbone of amino acid sequence, its function is often determined by PTMs, which specify stability, activity, or cellular localization. Among PTMs, ubiquitin and ubiquitin-like (Ubl) modifications were shown to regulate a variety of fundamental cellular processes such as cell division and differentiation. Aberrations in these pathways have been implicated in the pathogenesis of cancer. Over the past decade high-throughput genomic and transcriptional analyses have profoundly broadened our understanding of the processes underlying cancer development and progression. Yet, proteomic analyses and the PTM landscape in cancer, remained relatively unexplored. Our goal is to decipher molecular mechanisms of Ubl regulation in cancer. We will utilize the PTM profiling technology that I developed and further develop it to allow for subsequent MS analysis. Together with cutting-edge genomic, imaging and proteomic technologies, we will analyze novel aspects of PTM regulation at the level of the enzymatic machinery, the substrates and the downstream cellular network. We will rely on ample in-vitro and in-vivo characterization of Ubl conjugation to:a. Elucidate the regulatory principles of substrate specificity and recognition. b. Understand signalling dynamics in the ubiquitin system. c. Reveal how aberrations in these pathways may lead to diseases such as cancer. Identifying both the Ubl modifying enzymes and the modified substrates will form the basis for deciphering the molecular pathways in which they operate in the cell and the principles of their dynamic regulation. Revealing the PTM regulatory code presents a unique opportunity for the development of novel therapeutics. More broadly, our approaches may provide a new paradigm for addressing other complex biological questions involving PTM regulation.


year authors and title journal last update
List of publications.
2018 Hila Wolf-Levy, Aaron Javitt, Avital Eisenberg-Lerner, Assaf Kacen, Adi Ulman, Daoud Sheban, Bareket Dassa, Vered Fishbain-Yoskovitz, Carmelo Carmona-Rivera, Matthias P Kramer, Neta Nudel, Ifat Regev, Liron Zahavi, Dalia Elinger, Mariana J Kaplan, David Morgenstern, Yishai Levin, Yifat Merbl
Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides
published pages: 1110-1116, ISSN: 1087-0156, DOI: 10.1038/nbt.4279
Nature Biotechnology 36/11 2019-06-05
2017 Avital Eisenberg-Lerner, Ifat Regev, Yifat Merbl
Post-Translational Modification Profiling-Functional Proteomics for the Analysis of Immune Regulation
published pages: 139-152, ISSN: , DOI: 10.1007/978-1-4939-7201-2_9
Methods in Molecular Biology 2019-06-19
2016 Avital Eisenberg-Lerner, Aaron Ciechanover, Yifat Merbl
Post-translational modification profiling – A novel tool for mapping the protein modification landscape in cancer
published pages: 1475-1482, ISSN: 1535-3702, DOI: 10.1177/1535370216651732
Experimental Biology and Medicine 241/14 2019-06-19

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "UBL-CODE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "UBL-CODE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

NanoPD_P (2020)

High throughput multiplexed trace-analyte screening for diagnostics applications

Read More  


Precision medicine in traumatic brain injury using individual neurosteroid response

Read More  


Translating the Global Refined Analysis of Newly transcribed RNA and Decay rates by SLAM-seq

Read More